Dhivya R. Sudhan

Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer

Luigi Formisano, Yao Lu, Alberto Servetto et al. · Nature Communications · 2019 · 383 citations · Full text

Combined Blockade of Activating <i>ERBB2</i> Mutations and ER Results in Synthetic Lethality of ER+/HER2 Mutant Breast Cancer

Sarah Croessmann, Luigi Formisano, Lisa N. Kinch et al. · Clinical Cancer Research · 2018 · 109 citations · Full text

Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity

Ariella B. Hanker, Benjamin P. Brown, Jens Meiler et al. · Cancer Cell · 2021 · 92 citations · Full text

Systems Biology, Cell Regulation, Molecular Regulation +7

Cathepsin L inhibition by the small molecule KGP94 suppresses tumor microenvironment enhanced metastasis associated cell functions of prostate and breast cancer cells

Dhivya R. Sudhan, Dietmar W. Siemann · Clinical & Experimental Metastasis · 2013 · 71 citations · Full text

Medicine, Cathepsin L Inhibition, Cancer Cell Biology +7

Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER+ Breast Cancer

Alberto Servetto, Rahul K. Kollipara, Luigi Formisano et al. · Clinical Cancer Research · 2021 · 70 citations · Full text